Feasibility Studies Featured Articles
-
HIV/AIDS Vaccine Development: Are We Any Closer?
11/29/2012
With more than 20 years of lab experimentation of a HIV/AIDS vaccine, a leading researcher proves that the concept is possible, but must do better to create the vaccine.
-
Demystifying Fair Market Value
9/28/2012
Confusion exists over the definition of fair market value (FMV) when you ask any biopharmaceutical sponsor or investigative site and this article attempts to demystify some
basic factors related to FMV principles, with the goal of fostering improved understanding and dialogue on FMV issues. -
Can Rapid Mobile Diagnostics Speed Up Clinical Trials And Regulatory Reviews?
8/30/2012
As a new technological space containing all the alternatives, the most practical and immediate application for Rapid Mobile Diagnostics (RMDx) may be in clinical trials.
-
Changing The Outsourcing Paradigm – Who Is RDP Clinical Outsourcing?
5/1/2012
RDP takes a unique approach to the outsourcing of clinical services. We employ strategies wherever possible to exceed the goals of our sponsors in cost and timelines while maintaining excellence in quality.
-
Insights And A Peek Into The Future For PRO & ePRO
12/12/2011
PHT Corporation’s U.S. PRO & ePRO Congress, held in Boston Nov. 9-10, shared electronic patient reported outcome (ePRO) adoption growth numbers, discussions of new regulatory guidance, actionable information that can ease site and study subject burden from ePRO, PRO and ePRO in post-approval, and lingering reasons for sponsor reluctance to adopt ePRO. By Sara Gambrill